| Factor Information | |
|---|---|
| Data ID | 2127 |
| Factor | Previous cardiac procedure |
| Description | The SV group had significantly more previous sternotomies (P = .006) and longer bypass times (266 ± 78 vs 207 ± 64 minutes; P = .001) |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | We developed composite risk factor groups to better predict mortality after cardiac transplantation. |
| p Value | 0.006 |
| Conclusion | The SV group had significantly more previous sternotomies (P = .006) and longer bypass times (266 ± 78 vs 207 ± 64 minutes; P = .001) |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 148 |
| CHD Type | NA |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 23886031 |
| Year | 2013 |
| Title | Composite risk factors predict survival after transplantation for congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | a cross-sectional retrospective analysis | |
| Region | South Carolina,USA | |
| Method | univariate analysis, multivariate analysis | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | previous sternotomies | |
| Group | single ventricles (SVs) group(Treatment) | biventricular (BV) group(Control) |
| Number | 21 | 25 |
| Age | 8 ± 9 years | 10 ± 9years |
| Gender (Male: Female) | 13:09:00.000 | 15:10:00.000 |
| Marker Level | 20 (95%) | 15 (60%) |
